Analysis of circulating cell-free DnA identifies multiclonal heterogeneity of BRCA2 reversion mutations associated with resistance to PARP inhibitors

David Quigley, Joshi J. Alumkal, Alexander W. Wyatt, Vishal Kothari, Adam Foye, Paul Lloyd, Rahul Aggarwal, Won Kim, Eric Lu, Jacob Schwartzman, Kevin Beja, Matti Annala, Rajdeep Das, Morgan Diolaiti, Colin Pritchard, George Thomas, Scott Tomlins, Karen Knudsen, Christopher J. Lord, Charles RyanJack Youngren, Tomasz M. Beer, Alan Ashworth, Eric J. Small, Felix Y. Feng*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

211 Scopus citations

Fingerprint

Dive into the research topics of 'Analysis of circulating cell-free DnA identifies multiclonal heterogeneity of BRCA2 reversion mutations associated with resistance to PARP inhibitors'. Together they form a unique fingerprint.

Medicine and Dentistry